| Ellen Grisinger, CNM | |
|
3535 S Lafayette St Ste 100, Englewood, CO 80113 | |
| (303) 788-0600 | |
| (303) 788-0606 |
| Full Name | Ellen Grisinger |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 3535 S Lafayette St Ste 100, Englewood, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801347828 | NPI | - | NPPES |
| APN.0992785-CNM | Other | CO | COLORADO BOARD OF NURSING |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | APN.0992785-CNM (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ellen Grisinger, CNM Po Box 17030, Belfast, ME 04915-4065 Ph: () - | Ellen Grisinger, CNM 3535 S Lafayette St Ste 100, Englewood, CO 80113 Ph: (303) 788-0600 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
In a paper published in Molecular Frontiers Journal, researchers from Cambridge, Massachusetts have discovered a more effective way of eliminating airborne particles from airways using nasal calcium-rich salts called FEND, which have potential applications in the fight against Covid-19.
The art of tattooing may have found a diagnostic twist. A team of scientists in Germany have developed permanent dermal sensors that can be applied as artistic tattoos.
The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated metastatic colorectal cancer (mCRC), researchers announced at the ESMO 17th World Congress on Gastrointestinal Cancer 2015 in Barcelona.
A pair of brain-imaging studies suggest researchers may be able to predict how likely young adults are to develop problem drinking or engage in risky sexual behavior in response to stress.
› Verified 9 days ago
Drew Lawler, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 180 E Hampden Ave Ste 100, Englewood, CO 80113 Phone: 720-776-7059 | |
Ms. Erin Debra Jolene Stoesz, FNP-C, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 384 Inverness Pkwy Ste 115, Englewood, CO 80112 Phone: 720-635-9874 | |
Sara Jean Struckmeyer, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3535 S Lafayette St, Englewood, CO 80113 Phone: 303-788-0600 | |
Ms. Tracy E Ryan, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3535 S Lafayette St Ste 100, Englewood, CO 80113 Phone: 303-788-0600 Fax: 303-788-0602 | |
Mrs. Kristine N Combs, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 501 E Hampden Ave Fl 5, Englewood, CO 80113 Phone: 303-788-8550 Fax: 303-788-8554 | |
Mrs. Lauren Hamilton, MSN, CNM, CLC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 180 E Hampden Ave Ste 100, Englewood, CO 80113 Phone: 303-789-4968 Fax: 303-789-6018 | |
Tiffany Lynn Buss, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3535 S Lafayette St, #100, Englewood, CO 80113 Phone: 303-788-0600 |